• 975 Citations
  • 17 Scopus h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2005 2019

Filter
Article
2018

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S., Frank, R. D., Sharma, M., Roy, V., Ames, S., Rummans, T., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan Khan, A. A. & Ailawadhi, S., May 22 2018, In : Blood advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

Patient Acceptance of Health Care
Multiple Myeloma
Health Care Costs
Psychiatry
Comorbidity

Marantic endocarditis associated with T-Cell large granular lymphocytic leukemia: First report of its occurrence with a lymphoproliferative malignancy in adults

Ahmed, S., Jani, P., Yamani, M. H., Ailawadhi, S., Alegria, V. R. & Ailawadhi, M., Oct 1 2018, In : Journal of Oncology Practice. 14, 10, p. 625-627 3 p.

Research output: Contribution to journalArticle

Non-Infective Endocarditis
Large Granular Lymphocytic Leukemia
Neoplasms

Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma

Ailawadhi, S., Dholaria, B. R., Khurana, S., Sher, T., Alegria, V., Paulus, A., Ailawadhi, M., Mehta, A., Chanan Khan, A. A. & Roy, V., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Multiple Myeloma
2 Citations (Scopus)

Palliative Care Use Among Patients With Solid Cancer Tumors: A National Cancer Data Base Study

Osagiede, O., Colibaseanu, D. T., Spaulding, A., Frank, R. D., Merchea, A., Kelley, S. R., Uitti, R. J. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Journal of Palliative Care.

Research output: Contribution to journalArticle

Palliative Care
Databases
Neoplasms
Lung Neoplasms
Melanoma
9 Citations (Scopus)

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Multiple Myeloma
Dexamethasone
Appointments and Schedules
Therapeutics

Predictors of palliative treatment in stage IV colorectal cancer

Osagiede, O., Spaulding, A., Frank, R. D., Merchea, A., Uitti, R., Ailawadhi, S., Kelley, S. & Colibaseanu, D., Jan 1 2018, (Accepted/In press) In : American Journal of Surgery.

Research output: Contribution to journalArticle

Palliative Care
Colorectal Neoplasms
Survival
Medicaid
Quality of Life
1 Citation (Scopus)

Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials

Duma, N., Azam, T., Riaz, I. B., Gonzalez-Velez, M., Ailawadhi, S. & Go, R., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Multiple Myeloma
Clinical Trials
Hispanic Americans
Ethnic Groups
Research Personnel
3 Citations (Scopus)

Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma

Leleu, X., Martin, T. G., Einsele, H., Lyons, R. M., Durie, B. G. M., Iskander, K. S. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Multiple Myeloma
Therapeutics
Proteasome Endopeptidase Complex
Plasma Cells
4 Citations (Scopus)

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M., Patel, N. M., Miller, R. C., Adjei, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Therapeutics
Databases
Neoplasms
1 Citation (Scopus)

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan Khan, A. A. & Sher, T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytophagocytosis
Antibodies
B-Lymphocytes
Cell Death
3 Citations (Scopus)

The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study

Colibaseanu, D. T., Osagiede, O., Spaulding, A., Frank, R. D., Merchea, A., Mathis, K. L., Parker, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : American Journal of Hospice and Palliative Medicine.

Research output: Contribution to journalArticle

Palliative Care
Colorectal Neoplasms
Insurance Coverage
Survival
Logistic Models
35 Citations (Scopus)

Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase results from a single-group, phase 2, open-label study

Mahon, F. X., Boquimpani, C., Kim, D. W., Benyamini, N., Clementino, N. C. D., Shuvaev, V., Ailawadhi, S., Lipton, J. H., Turkina, A. G., De Paz, R., Moiraghi, B., Nicolini, F. E., Dengler, J., Sacha, T., Takahashi, N., Fellague-Chebra, R., Acharya, S., Wong, S., Jin, Y. & Hughes, T. P., Apr 3 2018, In : Annals of Internal Medicine. 168, 7, p. 461-470 10 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
8 Citations (Scopus)

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Ailawadhi, S., Frank, R. D., Sharma, M., Menghani, R., Temkit, M., Paulus, S., Khera, N. D., Hashmi, S., Advani, P., Swaika, A., Paulus, A., Aslam, N., Sher, T., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Costs and Cost Analysis
Survival
Hispanic Americans
1 Citation (Scopus)

Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma

Kumar, V., Garg, M., Chandra, A. B., Mayorga, V. S., Ahmed, S. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Hodgkin Disease
Neoplasms
Confidence Intervals
Incidence
14 Citations (Scopus)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D. M., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T., Lacy, M., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W., Rajkumar, S. V., Kumar, S. K., Gertz, M. & Roy, V., Jul 9 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-15 15 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Stem Cells
Transplants
Therapeutics
2019

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Ailawadhi, S., DerSarkissian, M., Duh, M. S., Lafeuille, M. H., Posner, G., Ralston, S., Zagadailov, E., Ba-Mancini, A. & Rifkin, R., Jan 1 2019, In : Clinical therapeutics.

Research output: Contribution to journalArticle

Multiple Myeloma
Costs and Cost Analysis
Therapeutics
Dexamethasone
Subcutaneous Infusions
4 Citations (Scopus)

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Appointments and Schedules
Neoplasms

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer

Duma, N., Idossa, D. W., Durani, U., Frank, R. D., Paludo, J., Westin, G., Lou, Y., Mansfield, A. S., Adjei, A. A., Go, R. S. & Ailawadhi, S., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Treatment Refusal
Drug Therapy
Therapeutics
Radiotherapy

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Siddiqi, T., Frankel, P., Beumer, J. H., Kiesel, B. F., Christner, S., Ruel, C., Song, J. Y., Chen, R., Kelly, K. R., Ailawadhi, S., Kaesberg, P., Popplewell, L., Puverel, S., Piekarz, R., Forman, S. J. & Newman, E. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Aurora Kinase A
Histone Deacetylase Inhibitors
Neoplasms
Appointments and Schedules
vorinostat
2 Citations (Scopus)

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S. & 1 others, Berdeja, J. G., Feb 1 2019, In : Blood cancer journal. 9, 2, 17.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Anti-Idiotypic Antibodies
Maximum Tolerated Dose
Antibodies
Pharmaceutical Preparations

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: A SEER-Medicare analysis

Ailawadhi, S., Parikh, K., Abouzaid, S., Zhou, Z., Tang, W., Clancy, Z., Cheung, C., Zhou, Z. Y. & Xie, J., Oct 22 2019, In : Blood Advances. 3, 20, p. 2986-2994 9 p.

Research output: Contribution to journalArticle

Open Access
Medicare
Multiple Myeloma
Epidemiology
Hispanic Americans
African Americans

Survival trends in glioblastoma and association with treating facility volume

Aulakh, S., DeDeo, M. R., Free, J., Rosenfeld, S., Quinones-Hinojosa, A., Paulus, A., Manna, A., Manochakian, R., Chanan Khan, A. A. & Ailawadhi, S., Jan 1 2019, In : Journal of Clinical Neuroscience.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Survival
Therapeutics
Neoplasms

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology
1 Citation (Scopus)

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia

Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., Heckman, M., Meghji, Z., Bhatia, K., Sharma, A., Sher, T., Alegria, V., Malavasi, F., Chini, E. N., Chanan Khan, A. A., Ailawadhi, S. & Paulus, A., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3974-3985 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Heterografts
B-Lymphocytes
Antibody-Dependent Cell Cytotoxicity
PCI 32765

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Survivors
Incidence
Survival Rate